DIANNA BRUNING: Open Payments
NPI 1508173618 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 36 payments from 15 companies in 2025. Trend: 2023 $1,663 · 2024 $1,743 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
| PFIZER INC. | 3 | $63 |
| GENZYME CORPORATION | 2 | $53 |
| Celltrion USA Inc. | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Ardelyx, Inc. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Organon LLC | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $21 |
Products named: DUPIXENT, ENTYVIO, VEGZELMA, VELSIPITY, RINVOQ, IBSRELA, SKYRIZI, CREON.
Industry payments across OH — which companies pay providers there.
